Holen Sie sich die Stockscreener-App
3.08
3.14%
-0.10
Schlusskurs vom Vortag:
$3.18
Offen:
$3.18
24-Stunden-Volumen:
17,097
Relative Volume:
0.33
Marktkapitalisierung:
$88.72M
Einnahmen:
$4.01M
Nettoeinkommen (Verlust:
$-38.53M
KGV:
-2.4444
EPS:
-1.26
Netto-Cashflow:
$-32.27M
1W Leistung:
+3.70%
1M Leistung:
+6.21%
6M Leistung:
-27.70%
1J Leistung:
-45.96%
1-Tages-Spanne:
$2.95
$3.18
1-Wochen-Bereich:
$2.95
$3.32
52-Wochen-Spanne:
$2.50
$8.32
Xbiotech Inc Stock (XBIT) Company Profile
Firmenname
Xbiotech Inc
Sektor
Branche
Telefon
512-386-2900
Adresse
5217 WINNEBAGO LANE, AUSTIN, TX
Vergleichen Sie XBIT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
3.08 | 88.72M | 4.01M | -38.53M | -32.27M | -1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.44 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
537.56 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.73 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.80 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.51 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-06-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-04-21 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-06-28 | Bestätigt | Noble Financial | Buy |
Xbiotech Inc Aktie (XBIT) Neueste Nachrichten
XBiotech (NASDAQ:XBIT) Stock Price Passes Below Fifty Day Moving AverageHere's Why - MarketBeat
XBiotech Inc. (NASDAQ:XBIT) Shares Sold by Millennium Management LLC - Defense World
Deutsche Bank AG Purchases New Shares in XBiotech Inc. (NASDAQ:XBIT) - Defense World
BNP Paribas Financial Markets Has $69,000 Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Aegon Ltd. (NYSE:AEG) Shares Sold by Millennium Management LLC - Defense World
Northern Trust Corp Buys 27,909 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech (NASDAQ:XBIT) Stock Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
XBiotech (NASDAQ:XBIT) Shares Cross Below 50 Day Moving AverageWhat's Next? - MarketBeat
Here's Why We're Not Too Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Situation - Yahoo Finance
Barclays PLC Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Barclays PLC Has $118,000 Stake in CureVac (NASDAQ:CVAC) - Defense World
XBiotech: Q1 Earnings Snapshot - New Haven Register
XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Shares Acquired by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Acquires 5,930 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
JPMorgan Chase & Co. Buys 2,250 Shares of Permian Basin Royalty Trust (NYSE:PBT) - Defense World
JPMorgan Chase & Co. Trims Stake in Clipper Realty Inc. (NYSE:CLPR) - Defense World
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
Investor Network: XBiotech, Inc. to Host Earnings Call - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
XBiotech (NASDAQ:XBIT) Stock Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat
Top Premarket Gainers - marketscreener.com
XBiotech (NASDAQ:XBIT) Shares Pass Above Fifty Day Moving AverageHere's Why - MarketBeat
XBiotech Inc. (NASDAQ:XBIT) Shares Sold by American Century Companies Inc. - Defense World
XBiotech stock plunges to 52-week low at $2.91 amid market challenges - Investing.com Canada
XBiotech Inc. (NASDAQ:XBIT) Short Interest Down 23.1% in March - MarketBeat
XBiotech Announces Board Member Retirement - TipRanks
XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving AverageWhat's Next? - MarketBeat
Bank of New York Mellon Corp Has $360,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT - ACCESS Newswire
Finanzdaten der Xbiotech Inc-Aktie (XBIT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.84%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):